Free shipping on all orders over $ 500

Apixaban

Cat. No. M1649
Apixaban Structure
Synonym:

BMS-562247-01

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 40  USD40 In stock
5mg USD 35  USD35 In stock
10mg USD 50  USD50 In stock
50mg USD 90  USD90 In stock
100mg USD 115  USD115 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Apixaban is a direct Human Factor Xa inhibitor with Ki of 0.08 nM. Apixaban prolongs the clotting times of normal human plasma with the concentrations (EC2x) of 3.6 μM, 0.37 μM, 7.4 μM and 0.4 μM in vitro. Apixaban significantly inhibits factor Xa activity with IC50 of 0.22 μM in rabbit ex vivo. In the arteriovenous-shunt thrombosis (AVST), venous thrombosis (VT) and electrically mediated carotid arterial thrombosis (ECAT) rabbit models, Apixaban produces dose-dependent antithrombotic effects with EC50 of 270 nM, 110 nM and 70 nM, respectively.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method Platelet aggregation assays
Platelet aggregation was measured in citrated human and rabbit platelet-rich plasma (PRP) in vitro with a platelet aggregometer (Model PAP-4D, BioData, Horsham, PA, USA). PRP was obtained from citrated blood after centrifuging at 250 · g for 6 min. Citrated PRP (250 μL) was mixed with 20 μL of vehicle, DMP802 at 3 μM or apixaban at 1–10 μM, and incubated for 3 min at 37℃. DMP802, a glycoprotein (GP)IIb/IIIa receptor antagonist, was included as a positive control (IC50 = 29 nM against human platelet aggregation response to 10 μM ADP). Peak platelet aggregation was determined after the addition of 20 μL of the agonist (ADP at 10 μM, c-thrombin at 35 nM, and collagen at 10 μg mL)1, final concentration).
Concentrations 1-10 μM
Incubation time 3 min
Animal Experiment
Animal models rat AVST model
Formulation 10% N,N-dimethylacetamide; 30% 1,2-propanediol; 60% water
Dosages 0.03, 0.1, 0.3, 1mg/kg/h
Administration intravenously
Chemical Information
Molecular Weight 459.5
Formula C25H25N5O4
CAS Number 503612-47-3
Solubility (25°C) DMSO 46 mg/mL
Storage Powder -20°C
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Carter et al. J Thromb Thrombolysis. Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins Hospital.

[2] Martin et al. Clin Med Insights Cardiol. Safety and efficacy of apixaban in the treatment of atrial fibrillation.

[3] Agrawal et al. Curr Drug Targets. Apixaban: a new player in the anticoagulant class.

[4] Connolly et al. N Engl J Med. Apixaban in patients with atrial fibrillation.

[5] Wong PC, et al. J Thromb Haemost. Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies.

Related Factor Xa Products
Suc-Ile-Glu(γ-pip)-Gly-Arg-pNA hydrochloride

Suc-Ile-Glu(γ-pip)-Gly-Arg-pNA hydrochloride is a factor Xa specific chromogenic substrate.

D-Pro-Phe-Arg-Chloromethylketone

D-Pro-Phe-Arg-Chloromethylketone, a inhibitor of coagulation factor XII and plasma kallikrein, plays an important role in thrombosis and inflammation.

Methoxycarbonyl-D-Nle-Gly-Arg-pNA

Methoxycarbonyl-D-Nle-Gly-Arg-pNA is a synthetic trypsin that can serve as a substrate for coagulation factors IXa (FIXa) and Xa (FXa).

Boc-Ile-Glu-Gly-Arg-AMC

Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC) is an activated factor X (FXa) specific fluorogenic peptide substrate used for Factor VIII determination.

Delparantag

Delparantag (PMX-60056) is a salicylamide derivative and an effective unfractionated heparin (UFH) and low molecular weight heparin (LMWH) reversing agent.

  Catalog
Abmole Inhibitor Catalog




Keywords: Apixaban, BMS-562247-01 supplier, Factor Xa, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.